Isogenica is Hiring

Isogenica is hiring to add strength and depth to our team and to increase our commitment to partnerships with biopharma


Isogenica is increasing our commitment to partnerships with biopharma.  We’ve seen important shifts in the way pharma and biotech want to engage with Isogenica, and we’re embracing the opportunity for change by adding strength and depth to our team so that we can continue to work as trusted partners with a wider group of pioneering biopharma companies. We’re recruiting to fill several vacancies including a newly created role of Director of Antibody Discovery and a Senior Scientist team lead role.

Posts will be advertised on our website now and over the coming weeks, so take a look and please get in touch if you, or someone you know, are interested in a role at Isogenica.


 Visit our jobs page


Isogenica is at the forefront of synthetic biology, pursuing a mission to provide the fastest, most efficient engine for therapeutic antibody discovery. We are passionate about using our platform technologies to improve and accelerate drug discovery and development. Working with pharmaceutical industry partners, we are driven by the ultimate goal of helping patients though more affordable medicines and faster access to potentially life changing treatments.





PEGS Summit Europe 2019

Lisbon, Portugal | 18th November to 22nd November 2019
Isogenica is pleased to be attending and presenting at PEGS Europe 2019. We look forward to meeting you there.

Read More

Bio Europe, Hamburg

Hamburg, Germany| 11th –13th 2019
Isogenica is excited to be attending Bio-Europe this year. 

Read More


Isogenica appoints Dr David Mead as Director of Business Development

Cambridge, UK, 12th September 2019

Dr David Mead will join Isogenica as Director of Business Development, effective immediately

Read More